{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:13:35Z","timestamp":1762506815763,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.cllc.2016.05.017","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T10:39:48Z","timestamp":1465641588000},"page":"517-522.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma"],"prefix":"10.1016","volume":"17","author":[{"given":"David M.","family":"DiBardino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Saqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Elvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Greenbowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siraj M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Stoopler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Bulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"Cancer Facts & Figures\u00a02012","key":"10.1016\/j.cllc.2016.05.017_bib1"},{"key":"10.1016\/j.cllc.2016.05.017_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.yexcr.2008.07.026","article-title":"ErbBs in lung cancer","volume":"315","author":"Sharma","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cllc.2016.05.017_bib3","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1200\/JCO.2010.28.8126","article-title":"The evolving role of histology in the management of advanced non\u2013small-cell lung cancer","volume":"28","author":"Langer","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.05.017_bib4","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non\u2013small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.05.017_bib5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1097\/JTO.0b013e3181f0bd93","article-title":"A\u00a0brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound and endobronchial ultrasound-guided fine needle cytological aspirates","volume":"5","author":"Schuurbiers","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.05.017_bib6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1200\/JCO.2010.31.8923","article-title":"American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non\u2013small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy","volume":"29","author":"Keedy","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.05.017_bib7","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2014.57.3055","volume":"10","author":"Leighl","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.05.017_bib8","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. Non\u2013small-cell Lung Cancer. V.2.2010. Updated Version 3.2011, Version 3.2012, Version 2.2013, Version 2, 2014. Version 3.2014. Updated Version 6.2015. Available at: http:\/\/www.jnccn.org\/content\/13\/5\/515.full. Accessed: December 21, 2015."},{"key":"10.1016\/j.cllc.2016.05.017_bib9","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2016.05.017_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jnci\/djt072","article-title":"Impact of EGFR inhibitor in non\u2013small-cell lung cancer on progression-free and overall survival: a meta-analysis","volume":"105","author":"Lee","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2016.05.017_bib11","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/annonc\/mdr489","article-title":"Implementing multiplexed genotyping of non\u2013small-cell lung cancers into routine clinical practice","volume":"22","author":"Sequist","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2016.05.017_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.2012.45.3753","article-title":"Genotyping and genomic profiling of non\u2013small-cell lung cancer: implications for current and future therapies","volume":"31","author":"Li","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.05.017_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/1742-6413.132989","article-title":"Molecular testing guidelines for lung adenocarcinoma: utility of cell blocks and concordance between fine-needle aspiration cytology and histology samples","volume":"11","author":"Heymann","year":"2014","journal-title":"Cytojournal"},{"key":"10.1016\/j.cllc.2016.05.017_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cncy.21507","article-title":"Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells","volume":"123","author":"Pareja","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cllc.2016.05.017_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cncy.21527","article-title":"FNA, core biopsy, or both for the diagnosis of lung carcinoma: obtaining sufficient tissue for a specific diagnosis and molecular testing","volume":"123","author":"Coley","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cllc.2016.05.017_bib16","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-13-0295","article-title":"Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations","volume":"19","author":"Ross","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2016.05.017_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/1078-0432.CCR-13-1992","article-title":"A\u00a0high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma","volume":"20","author":"Ross","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2016.05.017_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/modpathol.2013.122","article-title":"Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics","volume":"27","author":"Kanagal-Shamanna","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cllc.2016.05.017_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cncy.20199","article-title":"Improvement of cellularity on cell block preparations using the so called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration","volume":"120","author":"Yung","year":"2012","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cllc.2016.05.017_bib20","series-title":"Diagnosing Non\u2013Small-Cell Lung Carcinoma in Small Biopsy and Cytology","first-page":"39","article-title":"Adequacy and tissue preservation of small biopsy and cytology specimens","author":"Crapanzano","year":"2015"},{"key":"10.1016\/j.cllc.2016.05.017_bib21","series-title":"Diagnosing Non\u2013Small-Cell Lung Carcinoma in Small Biopsy and Cytology","first-page":"61","article-title":"Optimizing and triage of small specimens","author":"Saqi","year":"2015"},{"key":"10.1016\/j.cllc.2016.05.017_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small-cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730416301334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730416301334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:06:43Z","timestamp":1761505603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730416301334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1525730416301334"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2016.05.017","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2016.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}